<div class="white-sheet">
    <div class="content-slide">

<!-- Secondary scene 1 -->
    <div class="content secondary-scene">
        <!--<h1>Content</h1>-->
        

                <div class="title-bar red"></div>

                <div class="wrapper slide-2-3-2-3">

                    <div class="vertical-nav">
                        <ul class="two">
                            <li class="active"></li>
                            <li></li>
                        </ul>
                    </div>

                    <div class="popups" style="position:absolute">
                        <div data-effect="fade" data-duration="1000" data-target="references1-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>
                        <div data-effect="fade" data-duration="1000" data-target="information1-overlay" data-width="600" data-height="490" class="information-button show-overlay"></div>            
                    </div>

                    <div class="slide-title red">
                        Natural history of acquired aplastic anaemia
                    </div>


                    <div class="content-container">
                
                         <ul>
                         	<li><span>Patients with severe aplastic anaemia are usually asymptomatic prior to diagnosis<sup>1</sup></span>
								<ul>
									<li><span>They commonly seek medical attention because of symptoms of anaemia or haemorrhage</span></li>
									<li><span>Even if the patient has severe neutropenia, infection is uncommon at first presentation</span></li>
									<li><span>Initial reduction in blood count may be associated with a single blood cell lineage (single cell cytopenia)</span>
										<ul>
											<li><span>Commonly thrombocytopenia or anaemia</span></li>
										</ul>
									</li>
								</ul>
                         	</li>
                         	<li><span>A known complication of severe aplastic anaemia is the appearance of cytogenetic abnormalities in the haematopoietic stem cells of the bone marrow (a process also referred to as clonal evolution)<sup>2</sup></span>
								<ul>
									<li><span>For this reason, cytogenetic testing is performed in all studies of severe aplastic anaemia conducted by the National Institutes of Health (NIH)</span></li>
								</ul>
                         	</li>
                         	<li><span>The clinical consequences of cytogenetic abnormalities are variable, depending on the presence or absence of clinical sequelae such as dysplasia or worsening cytopenias<sup>2</sup></span>
								<ul>
									<li><span>Severe aplastic anaemia may progress to myelodysplastic syndrome (MDS) or leukaemia at a rate of ~10–20% per 5–10 years,<sup>1–3</sup> and evolution to MDS can occur either in early- or late-stage aplastic anaemia<sup>2</sup></span></li>
								</ul>
                         	</li>
                         	<li><span>Prognosis is poorer in severe aplastic anaemia patients who develop cytogenetic abnormalities compared with those who do not<sup>1</sup></span></li>

                         </ul>

                    </div>

                </div>


                <div class="information1-overlay overlay">

					<header>Natural history of acquired aplastic anaemia<sup>2</sup></header>
						
					<ul>
						<li><span>As cytogenetically normal haematopoietic stem cells become depleted, cells containing chromosomal abnormalities may be retained rather than destroyed by the immune system</span></li>
						<li><span>Ongoing depletion of haematopoietic stem cells creates a selection pressure that allows the this abnormal cell population to be preserved and to expand at a rapid rate</span></li>
						<li><span>The presence of mutant clones can eventually lead to disorders that arise from chromosomal abnormalities, including MDS, leukaemia and paroxysmal nocturnal haemoglobinuria</span></li>
					</ul>

				</div>


                <div class="references1-overlay overlay">

                    <header>References</header>
                        
                    <ul>
                        <li class="navigateHref" data-navtarget="media/documents/Pallister&Watson-2011-Haematology-v2p27-35.pdf"><span>Scheinberg P & Young NS. <i>Blood</i> 2012;120:1185</span></li>
                        <li class="navigateHref" data-navtarget="media/documents/Pallister&Watson-2011-Haematology-v2p27-35.pdf"><span>Afable MG <i>et al. Hematology Am Soc Hematol Educ Program</i> 2011;90</span></li>
                        <li class="navigateHref" data-navtarget="media/documents/Pallister&Watson-2011-Haematology-v2p27-35.pdf"><span>Maciejewski JP & Selleri C. <i>Leukaemia & Lymphoma</i> 2004:45:433</span></li>
                    </ul>

                </div>

          
    </div>
    <!-- End of secondary scene 1 -->
    <!-- Secondary scene 2 (Static Content) -->
    <div class="content secondary-scene">
         

                <div class="title-bar blue"></div>

                <div class="wrapper slide-2-3-2c">

                    <div class="vertical-nav">
                        <ul class="two">
                            <li></li>
                            <li class="active"></li>
                        </ul>
                    </div>

                    <div class="popups" style="position:absolute">
                        <div data-effect="fade" data-duration="1000" data-target="references2-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>          
                        <div data-effect="fade" data-duration="1000" data-target="information2-overlay" data-width="600" data-height="490" class="information-button show-overlay"></div>    
                    </div>

                    <div class="slide-title blue">
                        Cytogenetic abnormalities in severe acquired aplastic anaemia
                    </div>


                    <div class="content-container">
                
                        <div class="content-left">

                        	<ul>
                        		<li><span>Acquired aplastic anaemia may co-exist with, or evolve into, clonal disorders<sup>1</sup></span></li>
                        		<li><span>HSC depletion may cause the recruitment of a genetically defective clone<sup>2</sup></span>
									<ul>
										<li><span>Paroxysmal nocturnal haemoglobinuria (PNH)<sup>1</sup></span>
											<ul>
												<li><span>~40–50% of patients with acquired aplastic anaemia have higher PNH cell counts</span></li>
												<li><span>Classic PNH can evolve in to marrow failure</span></li>
												<li><span>All patients with PNH show evidence of haematopoietic deficiency</span></li>
											</ul>
										</li>
										<li><span>MDS<sup>1</sup></span>
											<ul>
												<li><span>Aneuploidy (abnormal chromosome number)</span></li>
												<li><span>Usually monosomy 7 and trisomy 8</span>
													<ul>
														<li><span>Monosomy 7 is associated with refractory cytopenia or AML</span></li>
													</ul>
												</li>
											</ul>
										</li>
									</ul>
                        		</li>
                        	</ul>
                            
                        </div>


                        <div class="content-right">
                            <div class="blue-label">Potential consequences of bone marrow injury<sup>3</sup></div>
                            
                                <img src="media/images/slide_2-3-2c/picture1.png" alt="" width="442">
                            
                        </div>


                    </div>

                </div>

                <div class="information2-overlay overlay">

                    <header>Cytogenetic abnormalities in severe acquired aplastic anaemia</header>
                        
                    <ul>
                        <li><span>Bone marrow injury may be associated with three possible consequences:<sup>3</sup></span>
							<ul>
								<li><span>Generation of an autoimmune reaction against HSCs or progenitors</span></li>
								<li><span>Induction of a genetic mutation in HSCs resulting in clonal expansion</span></li>
								<li><span>Both an autoimmune reaction against, and clonal expansion of, HSCs</span></li>
							</ul>
                        </li>
                        <li><span>Depending on the rate of clonal growth, clonality may occur:<sup>3</sup></span>
							<ul>
								<li><span>Simultaneously with the autoimmune attack (aplastic anaemia/paroxysmal nocturnal haemoglobinuria overlap or hypoplastic myelodysplasia)</span></li>
								<li><span>Subsequent to the autoimmune attack (secondary clonal disease)</span></li>
							</ul>
                        </li>
                        <li><span>Cytogenically abnormal clones may:<sup>2</sup></span>
							<ul>
								<li><span>Trigger an autoimmune tumour surveillance response that eliminates the abnormal cells, but also destroys healthy HSCs</span></li>
								<li><span>Create a selection pressure that leads to the generation and escape of mutant clones that outgrow normal haematopoiesis</span></li>
							</ul>
                        </li>
                    </ul>

                </div>


                <div class="references2-overlay overlay">

                    <header>References</header>
                        
                    <ol>
                        <li class="navigateHref" data-navtarget="media/documents/TavianM-2005-InJDevBiol-v49p243.pdf"><span>Young NS <i>et al. Curr Opin Hematol</i> 2008;15:162</span></li>
                        <li class="navigateHref" data-navtarget="media/documents/Pallister&Watson-2011-Haematology-v2p17-27.pdf"><span>Afable MG <i>et al. Hematology Am Soc Hematol Educ Program</i> 2011;90</span></li>
                        <li class="navigateHref" data-navtarget="media/documents/Pallister&Watson-2011-Haematology-v2p17-27.pdf"><span>Brodsky RA & Jones RJ. <i>Lancet</i> 2005;365:1647</span></li>
                    </ol>

                </div>

          
    </div>
    <!-- End of secondary scene 2 -->

    </div>
 </div>